Glenmark Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
29416.70 Cr.
|
P/BV
|
3.11
|
Book Value (Rs.)
|
335.73
|
52 Week High/Low (Rs.)
|
1098/581
|
FV/ML
|
1/1
|
P/E(X)
|
98.97
|
Bookclosure
|
29/09/2023
|
EPS (Rs.)
|
10.53
|
Div Yield (%)
|
0.24
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 10.53 | 33.37 | 34.38 | 27.50 | 32.78 |
Diluted EPS (Rs.) | 10.53 | 33.37 | 34.38 | 27.50 | 32.78 |
Cash EPS (Rs.) | 35.04 | 52.46 | 50.10 | 42.28 | 44.33 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 348.70 | 334.48 | 250.36 | 215.12 | 198.63 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 348.70 | 334.48 | 250.36 | 215.12 | 198.63 |
Revenue From Operations / Share (Rs.) | 460.36 | 436.08 | 387.85 | 377.11 | 349.63 |
PBDIT / Share (Rs.) | 91.97 | 88.14 | 75.65 | 65.84 | 63.58 |
PBIT / Share (Rs.) | 70.31 | 70.89 | 59.93 | 51.05 | 52.03 |
PBT / Share (Rs.) | 30.78 | 51.08 | 48.99 | 38.84 | 46.09 |
Net Profit / Share (Rs.) | 13.37 | 35.21 | 34.38 | 27.50 | 32.78 |
NP After MI And SOA / Share (Rs.) | 10.53 | 33.37 | 34.38 | 27.50 | 32.78 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 19.97 | 20.21 | 19.50 | 17.45 | 18.18 |
PBIT Margin (%) | 15.27 | 16.25 | 15.45 | 13.53 | 14.88 |
PBT Margin (%) | 6.68 | 11.71 | 12.63 | 10.30 | 13.18 |
Net Profit Margin (%) | 2.90 | 8.07 | 8.86 | 7.29 | 9.37 |
NP After MI And SOA Margin (%) | 2.28 | 7.65 | 8.86 | 7.29 | 9.37 |
Return on Networth / Equity (%) | 3.13 | 10.36 | 13.73 | 12.78 | 16.50 |
Return on Capital Employeed (%) | 13.84 | 16.13 | 14.83 | 13.64 | 15.82 |
Return On Assets (%) | 1.53 | 5.51 | 6.21 | 5.28 | 6.95 |
Long Term Debt / Equity (X) | 0.40 | 0.28 | 0.55 | 0.66 | 0.63 |
Total Debt / Equity (X) | 0.45 | 0.40 | 0.66 | 0.73 | 0.69 |
Asset Turnover Ratio (%) | 0.71 | 0.42 | 0.42 | 0.41 | 0.42 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 1.96 | 1.77 | 1.75 | 1.65 | 1.67 |
Quick Ratio (X) | 1.37 | 1.23 | 1.21 | 1.13 | 1.11 |
Inventory Turnover Ratio (X) | 1.31 | 1.85 | 1.85 | 1.46 | 1.08 |
Dividend Payout Ratio (NP) (%) | 23.73 | 7.49 | 7.27 | 8.76 | 7.35 |
Dividend Payout Ratio (CP) (%) | 7.76 | 4.93 | 4.99 | 5.70 | 5.43 |
Earning Retention Ratio (%) | 76.27 | 92.51 | 92.73 | 91.24 | 92.65 |
Cash Earning Retention Ratio (%) | 92.24 | 95.07 | 95.01 | 94.30 | 94.57 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 7.42 | 8.34 | 6.04 | 4.92 | 5.36 |
Interest Coverage Ratio (Post Tax) (%) | 4.27 | 5.21 | 3.62 | 2.97 | 3.26 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 16364.27 | 15087.86 | 16656.12 | 9188.07 | 21154.12 |
EV / Net Operating Revenue (X) | 1.26 | 1.23 | 1.52 | 0.86 | 2.14 |
EV / EBITDA (X) | 6.31 | 6.07 | 7.80 | 4.95 | 11.79 |
MarketCap / Net Operating Revenue (X) | 1.01 | 1.01 | 1.20 | 0.54 | 1.85 |
Retention Ratios (%) | 76.26 | 92.50 | 92.72 | 91.23 | 92.64 |
Price / BV (X) | 1.38 | 1.37 | 1.86 | 0.95 | 3.25 |
Price / Net Operating Revenue (X) | 1.01 | 1.01 | 1.20 | 0.54 | 1.85 |
EarningsYield | 0.02 | 0.07 | 0.07 | 0.13 | 0.05 |